These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Deficient prolactin response to parathyroid hormone in hypocalcemic and normocalcemic pseudohypoparathyroidism. Kruse K; Gutekunst B; Kracht U; Schwerda K J Clin Endocrinol Metab; 1981 Jun; 52(6):1099-105. PubMed ID: 6262363 [TBL] [Abstract][Full Text] [Related]
43. Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism. Neer RM; Tregear GW; Potts JT J Clin Endocrinol Metab; 1977 Feb; 44(2):420-3. PubMed ID: 190258 [TBL] [Abstract][Full Text] [Related]
44. The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients. Ishii A; Imanishi Y; Kurajoh M; Nagata Y; Kobayashi K; Miki T; Inaba M; Nishizawa Y Endocr J; 2010; 57(7):609-14. PubMed ID: 20508384 [TBL] [Abstract][Full Text] [Related]
45. Vitamin D deficiency in two young adults with biochemical findings resembling pseudohypoparathyroidism type I and type II. Seki T; Yamamoto M; Kimura H; Tsuiki M; Ono M; Miki N; Takano K; Sato K Endocr J; 2010; 57(8):735-44. PubMed ID: 20505259 [TBL] [Abstract][Full Text] [Related]
46. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type Ib. Silve C; Santora A; Breslau N; Moses A; Spiegel A J Clin Endocrinol Metab; 1986 Apr; 62(4):640-4. PubMed ID: 3005354 [TBL] [Abstract][Full Text] [Related]
47. Pseudohypoparathyroidism presenting with rickets. Wilson JD; Hadden DR J Clin Endocrinol Metab; 1980 Nov; 51(5):1184-9. PubMed ID: 7419691 [TBL] [Abstract][Full Text] [Related]
48. Plasma levels of parathyroid hormone (1-84) whole molecule and parathyroid hormone (7-84)-like fragments in pseudohypoparathyroidism type I. Hatakeyama Y; Mizunashi K; Furukawa Y; Yabuki S; Sato Y; Igarashi T J Clin Endocrinol Metab; 2003 May; 88(5):2250-5. PubMed ID: 12727982 [TBL] [Abstract][Full Text] [Related]
49. Effect of acute cimetidine administration on indices of parathyroid hormone action in healthy subjects and patients with primary and secondary hyperparathyroidism. Glaser B; Kraiem Z; Rotem M; Gonda M; Bernheim J; Sheinfeld M J Clin Endocrinol Metab; 1984 Nov; 59(5):993-7. PubMed ID: 6090499 [TBL] [Abstract][Full Text] [Related]
50. Phenotypic and molecular genetic aspects of pseudohypoparathyroidism type Ib in a Greek kindred: evidence for enhanced uric acid excretion due to parathyroid hormone resistance. Laspa E; Bastepe M; Jüppner H; Tsatsoulis A J Clin Endocrinol Metab; 2004 Dec; 89(12):5942-7. PubMed ID: 15579741 [TBL] [Abstract][Full Text] [Related]
51. Decreased sensitivity of distal nephron and collecting duct to parathyroid hormone in pseudohypoparathyroidism type I. Goto M; Mizunashi K; Kimura N; Furukawa Y J Am Soc Nephrol; 2001 Sep; 12(9):1965-1970. PubMed ID: 11518791 [TBL] [Abstract][Full Text] [Related]
52. Genetics and epigenetics of parathyroid hormone resistance. Bastepe M Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091 [TBL] [Abstract][Full Text] [Related]
53. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism. Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461 [TBL] [Abstract][Full Text] [Related]
54. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP. Duck SC; Rosenberg EM; Ratzan SK; Haymond MW J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678 [TBL] [Abstract][Full Text] [Related]
55. Parathyroid hormone infusion test in children and adolescents. Hochberg Z; Moses AM; Richman RA Miner Electrolyte Metab; 1984; 10(2):113-6. PubMed ID: 6321936 [TBL] [Abstract][Full Text] [Related]
56. Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations. Kutílek S; Kabícek P; Nedvídková J; Bayer M Turk J Pediatr; 2001; 43(1):70-5. PubMed ID: 11297164 [TBL] [Abstract][Full Text] [Related]
57. Hypoparathyroidism and pseudohypoparathyroidism. Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292 [TBL] [Abstract][Full Text] [Related]
58. Separation of pseudohypoparathyroidism into types I and II using only basal nephrogenous cAMP determinations. Singhellakis P; Pappas A; Nicolou CH; Ikkos D Endocrinologie; 1991; 29(1-2):67-71. PubMed ID: 1666440 [TBL] [Abstract][Full Text] [Related]
59. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3',5'-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: an acquired disorder resembling pseudohypoparathyroidism type II. Rao DS; Parfitt AM; Kleerekoper M; Pumo BS; Frame B J Clin Endocrinol Metab; 1985 Aug; 61(2):285-90. PubMed ID: 2989317 [TBL] [Abstract][Full Text] [Related]
60. Effects of dibutyryl cyclic adenosine 3',5'-monophosphate and parathyroid extract on calcium and phosphorus metabolism in hypoparathyroidism and pseudohypoparathyroidism. Bell NH; Avery S; Sinha T; Clark CM; Allen DO; Johnston C J Clin Invest; 1972 Apr; 51(4):816-23. PubMed ID: 4335445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]